SYNERGY CHC CORP (NASDAQ:SNYR) Reports Q3 2025 Revenue Miss, Stock Declines

Third Quarter 2025 Financial Results

SYNERGY CHC CORP (NASDAQ:SNYR) has announced its financial results for the third quarter of 2025, marking its eleventh consecutive quarter of profitability. The consumer health and wellness company reported revenue and earnings per share that fell short of analyst expectations, a development that appears to be influencing early market sentiment.

Earnings and Revenue Versus Estimates

The core figures from the earnings release show a clear divergence from what market analysts had projected for the quarter.

• Reported Revenue: $8.01 million
• Estimated Revenue: $11.12 million
• Reported Non-GAAP EPS: $0.01
• Estimated Non-GAAP EPS: $0.0102

While the company managed to meet its profitability streak and delivered an earnings per share figure nearly in line with estimates, the revenue miss is significant. The reported sales of $8.01 million fell approximately 28% short of the $11.12 million consensus estimate. This top-line underperformance suggests that despite maintaining operational discipline to stay profitable, the company's sales generation for the quarter was weaker than anticipated.

Market Reaction and Price Action

The immediate market reaction to the earnings report has been negative. In pre-market trading, the stock is indicating a decline of approximately 2.74%. This initial price action is a direct reflection of investor disappointment, primarily centered on the substantial revenue miss. The negative momentum extends beyond the immediate reaction, with the stock showing declines across recent timeframes.

• Last Week Performance: -6.61%
• Last Two Weeks Performance: -6.19%
• Last Month Performance: -3.20%

This pattern indicates that concerns may have been building in the lead-up to the earnings announcement, with the confirmed revenue shortfall solidifying the negative trend.

Looking Ahead

The press release from Synergy CHC Corp. announced the results but did not provide a specific financial outlook for the upcoming quarter or the full year. The absence of forward-looking guidance means investors are left to weigh the company's recent performance against existing analyst projections without management's input. For context, analysts have already set expectations for the next period.

• Q4 2025 Estimated Revenue: $16.32 million
• Q4 2025 Estimated EPS: $0.1326
• Full-Year 2025 Estimated Revenue: $44.06 million
• Full-Year 2025 Estimated EPS: $0.4182

Achieving these targets, especially the significant sequential jump in Q4 revenue, will be a critical test for the company as it seeks to reassure investors about its growth trajectory following the Q3 sales miss.

Press Release Summary

The primary announcement from Synergy CHC Corp. centered on the confirmation of its eleventh straight profitable quarter. The release highlighted the company's position as a leader in the consumer health and wellness space, marketing brands such as FOCUSfactor and Flat Tummy. Beyond the raw financials, the consistent profitability was framed as a key indicator of the company's operational stability and business model resilience.

For a detailed breakdown of historical earnings and future analyst estimates, you can review the data available here: SNYR Earnings & Estimates.

---

Disclaimer: This article is for informational purposes only and is not intended as investment advice. The analysis is based on publicly available data and should not be construed as a recommendation to buy or sell any security. All investment decisions involve risk and individuals should conduct their own research.